45th week of 2016 patent applcation highlights part 8 |
Patent application number | Title | Published |
20160324764 | Particle-Free Microdermabrasion Formulations | 2016-11-10 |
20160324765 | DENTAL HYGIENE SYSTEMS | 2016-11-10 |
20160324766 | Prebiotic Oral Care Compositions Containing Amino Acids | 2016-11-10 |
20160324767 | ALLERGEN DOSAGE FORM | 2016-11-10 |
20160324768 | TRANSMUCOSAL DELIVERY DEVICES WITH ENHANCED UPTAKE | 2016-11-10 |
20160324769 | TOPICAL COMPOSITION COMPRISING EXTRACTS OF BOLDO AND OF MEADOWSWEET, INTENDED FOR AN ANIMAL, AND USES THEREOF | 2016-11-10 |
20160324770 | INTRATHECAL ADMINISTRATION, PREFERABLY INTRAVENTRICULAR, OF MTOR INHIBITORS FOR THE THERAPY OF SOME NEURODEGENERATIVE, NEUROINFLAMMATORY AND NEURO-ONCOLOGIC DISEASES | 2016-11-10 |
20160324772 | OPTIMIZED PHARMACEUTICAL FORMULATION FOR THE TREATMENT OF INFLAMMATORY CONDITIONS OF THE ESOPHAGUS | 2016-11-10 |
20160324773 | FILM DOSAGE FORMS CONTAINING AMORPHOUS ACTIVE AGENTS | 2016-11-10 |
20160324774 | INGESTIBLE FORMULATIONS FOR TRANSIENT, NONINVASIVE REDUCTION OF GASTRIC VOLUME | 2016-11-10 |
20160324775 | NOVEL AEROSOL FORMULATIONS OF ONDANSETRON AND USES THEREOF | 2016-11-10 |
20160324776 | Cannabinoid caffeinated drinks, powder, beans, and cannabinoid loose tea leaf | 2016-11-10 |
20160324777 | Tea Composition For Oral Administration | 2016-11-10 |
20160324778 | MEDICAMENT DELIVERY FORMULATIONS, DEVICES AND METHODS | 2016-11-10 |
20160324779 | Targeted Lipid-Drug Formulations for Delivery of Drugs to Myeloid and Lymphoid Immune Cells | 2016-11-10 |
20160324780 | REMOTE LOADING OF SPARINGLY WATER-SOLUBLE DRUGS INTO LIPOSOMES | 2016-11-10 |
20160324781 | NOVEL LIPIDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF BIOLOGICALLY ACTIVE COMPOUNDS | 2016-11-10 |
20160324782 | Oral Rapamycin Nanoparticle Preparations and Use | 2016-11-10 |
20160324783 | SINGLE VIAL VACCINE FORMULATIONS | 2016-11-10 |
20160324784 | MULTIPLE UNIT DOSAGE FORM HAVING A THERAPEUTIC AGENT IN COMBINATION WITH A NUTRITIONAL SUPPLEMENT | 2016-11-10 |
20160324785 | Pharmaceutical Composition | 2016-11-10 |
20160324786 | SOLID PREPARATIONS CONTAINING TOFOGLIFLOZIN AND PROCESS OF PRODUCING THE SAME | 2016-11-10 |
20160324787 | METHOD FOR THE PRODUCTION OF A MOLDING | 2016-11-10 |
20160324788 | FORMULATIONS OF 3-(6-(1-(2,2-DIFLUOROBENZO[D][1,3]DIOXOL-5-YL) CYCLOPROPANECARBOXAMIDO)-3-METHYLPYRIDIN-2-YL)BENZOIC ACID | 2016-11-10 |
20160324789 | PHARMACEUTICAL COMPOSITION CONTAINING CLOMIPRAMINE AND PREPARATION METHOD THEREFOR | 2016-11-10 |
20160324790 | AQUEOUS COMPOSITION FOR HARD CAPSULE, AND HARD CAPSULE PRODUCED USING SAME | 2016-11-10 |
20160324791 | CAPSULE PHARMACEUTICAL DOSAGE FORM COMPRISING A SUSPENSION FORMULATION OF AN INDOLINONE DERIVATIVE | 2016-11-10 |
20160324792 | CRYSTALLINE MICROPARTICLES OF A BETA-AGONIST COATED WITH A FATTY ACID | 2016-11-10 |
20160324793 | MODIFIED ALGINATES FOR CELL ENCAPSULATION AND CELL THERAPY | 2016-11-10 |
20160324794 | EXOSOME DELIVERY TECHNOLOLGY | 2016-11-10 |
20160324795 | SILIBININ NANOPARTICLE AND A METHOD OF TREATING HEPATITIS C THEREOF | 2016-11-10 |
20160324796 | COMPOSITIONS AND THEIR USE TO TREAT COMPLICATIONS OF ANEURYSMAL SUBARACHNOID HEMMORRHAGE | 2016-11-10 |
20160324797 | PLACENTAL TISSUE ASSEMBLY | 2016-11-10 |
20160324798 | POLYMER-BASED COMPOSITIONS FOR EXTENDED RELEASE OF PROTEINS | 2016-11-10 |
20160324799 | TRANSDERMAL THERAPEUTIC SYSTEM WITH HIGH RATE OF UTILIZATION OF ACTIVE SUBSTANCE AND DOSING ACCURACY | 2016-11-10 |
20160324800 | Visual Performance and/or Macular Pigmentation | 2016-11-10 |
20160324801 | AUGMENTATION OF ONCOLOGY IMMUNOTHERAPIES BY PTEROSTILBENE CONTAINING COMPOSITIONS | 2016-11-10 |
20160324802 | METHOD FOR PRE-SCREENING AND CORRELATION OF UNDERLYING SCARB1 GENE VARIATION TO ATHEROSCLEROSIS IN WOMEN AND THERAPEUTIC USE OF PROGESTATIONAL AND OTHER MEDICATIONS IN TREATMENT | 2016-11-10 |
20160324803 | MODIFIED RELEASE FORMULATIONS OF MEMANTINE ORAL DOSAGE FORMS | 2016-11-10 |
20160324804 | Dosage Forms and Related Therapies | 2016-11-10 |
20160324805 | INTRAVENOUS ADMINISTRATION OF TRAMADOL | 2016-11-10 |
20160324806 | PARTICULATE MATERIALS | 2016-11-10 |
20160324807 | BUPROPION AS A MODULATOR OF DRUG ACTIVITY | 2016-11-10 |
20160324808 | METHOD OF TREATING CANCER USING SELECTIVE ESTROGEN RECEPTOR MODULATORS | 2016-11-10 |
20160324809 | LYOPHILIZED MESNA COMPOSITIONS | 2016-11-10 |
20160324810 | Methods for Alleviating Statin Myopathy | 2016-11-10 |
20160324811 | METHODS OF REDUCING SMALL, DENSE LDL PARTICLES | 2016-11-10 |
20160324812 | Treatment of NAFLD and NASH | 2016-11-10 |
20160324813 | MEGALIN ANTAGONIST | 2016-11-10 |
20160324814 | COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF METABOLIC SYNDROME | 2016-11-10 |
20160324815 | AGENT FOR TREATING DIABETES | 2016-11-10 |
20160324816 | FATTY-ACID BASED PARTICLES | 2016-11-10 |
20160324817 | CONTROLLED RELEASE FATTY ACID COMPOSITIONS FOR USE IN BODY RECONSTRUCTION AND BODY-SHAPING | 2016-11-10 |
20160324818 | DIET FOOD COMPOSITION INCLUDING DHA TO REDUCE SHORT-TERM AND LONG-TERM LOW-GRADE INFLAMMATION | 2016-11-10 |
20160324819 | USE OF PUFAS FOR TREATING SKIN INFLAMMATION | 2016-11-10 |
20160324820 | PHARMACEUTICAL COMPOSITIONS COMPRISING 15-HEPE AND METHODS OF TREATING ASTHMA AND LUNG DISORDERS USING SAME | 2016-11-10 |
20160324821 | COMPOUNDS CONTAINING S-N-VALERYL-N--VALINE AND (2R,4S)-5-BIPHENYL-4-YL-4-(3-CARBOXY-PROPIONYLAMINO)-2-METHYL-PENTANOIC ACID ETHYL ESTER MOIETIES AND CATIONS | 2016-11-10 |
20160324822 | DOSAGE REGIMEN OF FERRIC TRIMALTOL | 2016-11-10 |
20160324823 | TREATMENT OF MITOCHONDRIAL DISEASES | 2016-11-10 |
20160324824 | COSMETIC COMPOSITION CONTAINING HYDROXY PYRANONE DERIVATIVE COMPOUND FOR PROMOTING DIFFERENTIATION OF ADIPOCYTES | 2016-11-10 |
20160324825 | USE OF ATRACTYLENOLIDE COMPOUND OR ITS DERIVATIVES AND A MEDICAMENT FOR INHIBITING PLATELET AGGREGATION | 2016-11-10 |
20160324826 | METHOD FOR PROVIDING AN INCREASED EXPRESSION OF TELOMERASE, BRAIN-DERIVED NEUROTROPHIC FACTOR, STROMAL CELL-DERIVED FACTOR-1, CXC CHEMOKINE RECEPTOR 4, AND/OR IMMUNE REGULATORY FACTOR OF STEM CELL | 2016-11-10 |
20160324827 | TOPICAL ANTI-INFLAMMATORY PHARMACEUTICAL COMPOSITION WITH ZILEUTON CREAM FORMULATION | 2016-11-10 |
20160324828 | INDOLE AMIDE DERIVATIVES AND RELATED COMPOUNDS FOR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES | 2016-11-10 |
20160324829 | COMBINATION THERAPY WITH PARP INHIBITORS | 2016-11-10 |
20160324830 | Method of Treating Multiple Sclerosis | 2016-11-10 |
20160324831 | Pharmaceutical Composition Comprising Deferasirox | 2016-11-10 |
20160324832 | USE OF ALKYLAMIDOTHIAZOLES IN COSMETIC OR DERMATOLOGICAL PREPARATIONS FOR THE PROPHYLAXIS OR TREATMENT OF SENSITIVE SKIN | 2016-11-10 |
20160324833 | INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL | 2016-11-10 |
20160324834 | Use of mTOR Inhibitors to Enhance T Cell Immune Responses | 2016-11-10 |
20160324835 | METHODS FOR IMPROVING MUSCLE STRENGTH | 2016-11-10 |
20160324836 | INJECTABLE DEPOT FORMULATIONS | 2016-11-10 |
20160324837 | Liquid Pharmaceutical Composition | 2016-11-10 |
20160324838 | PHARMACEUTICAL FORMULATIONS COMPRISING A PYRIDYLAMINOACETIC ACID COMPOUND | 2016-11-10 |
20160324839 | Dosing Regimens for the Treatment of Lysosomal Storage Diseases Using Pharmacological Chaperones | 2016-11-10 |
20160324840 | SUSTAINED RELEASE AMINOPYRIDINE COMPOSITION | 2016-11-10 |
20160324841 | MATERNAL VITAMIN B6 ADMINISTRATION FOR THE PREVENTION OF INCREASED ADIPOSITY, OVERWEIGHT OR OBESITY IN THE OFFSPRING | 2016-11-10 |
20160324842 | METHOD OF PROVIDING PIRFENIDONE THERAPY TO A PATIENT | 2016-11-10 |
20160324843 | PHARMARCEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER, CONTAINING PROTEASOME INHIBITOR AND LOPERAMIDE AS ACTIVE INGREDIENTS | 2016-11-10 |
20160324844 | Method of Inhibiting the Glycation of Nutrient and Endogenous Proteins and Peroxidation of Nutrient and Endogenous Lipids | 2016-11-10 |
20160324845 | NICOTINE SALT WITH META-SALICYLIC ACID AND APPLICATIONS THEREIN | 2016-11-10 |
20160324846 | Pharmaceutical Compositions for the Treatment of CFTR Mediated Diseases | 2016-11-10 |
20160324847 | ANTI-MALARIAL AGENT | 2016-11-10 |
20160324848 | Parenteral Formulations Of Dopamine Agonists | 2016-11-10 |
20160324849 | ABUSE-RESISTANT MUCOADHESIVE DEVICES FOR DELIVERY OF BUPRENORPHINE | 2016-11-10 |
20160324850 | Methods and Compositions for Treating Degenerative and Ischemic Disorders | 2016-11-10 |
20160324851 | METHODS OF TREATING A NEURODEGENERATIVE DISEASE | 2016-11-10 |
20160324852 | COMPOSITIONS AND METHODS OF TREATING A NEURODEGENERATIVE DISEASE | 2016-11-10 |
20160324853 | TRAZODONE AND TRAZODONE HYDROCHLORIDE IN PURIFIED FORM | 2016-11-10 |
20160324854 | PHARMACEUTICAL COMPOSITIONS COMPRISING AZD9291 | 2016-11-10 |
20160324855 | COMBINATION OF A 6-OXO-1,6-DIHYDRO-PYRIDAZINE DERIVATIVE HAVING ANTI-CANCER ACTIVITY WITH GEFITINIB | 2016-11-10 |
20160324856 | USE OF SGC STIMULATORS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS | 2016-11-10 |
20160324857 | METHOD FOR TREATING SHINGLES WITH N-METHANOCARBATHYMIDINE (N-MCT) | 2016-11-10 |
20160324858 | COMPOSITIONS AND METHODS OF TREATMENT OF CANCER | 2016-11-10 |
20160324859 | USE OF INHIBITORS OF BRUTON'S TYROSINE KINASE (BTK) | 2016-11-10 |
20160324860 | PRODUCTS AND PHARMACEUTICAL COMPOSITIONS | 2016-11-10 |
20160324861 | SUBSTITUTED PYRROLOPYRIMIDINE COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH | 2016-11-10 |
20160324862 | ADRENOCEPTORS ANTAGONISTS FOR THE PREVENTION AND TREATMENT OF NEURODEGENERATIVE CONDITIONS | 2016-11-10 |
20160324863 | TARGETED CANCER TREATMENT BY HSP90 INHIBITORS GANETESPIB AND NVP-AUY922 | 2016-11-10 |
20160324864 | SUBSTITUTED PYRIDOPYRAZINES AS NOVEL SYK INHIBITORS | 2016-11-10 |